Tissue Dependent Megakaryocyte Functions

组织依赖性巨核细胞功能

基本信息

  • 批准号:
    10569096
  • 负责人:
  • 金额:
    $ 50.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-02-08 至 2026-01-31
  • 项目状态:
    未结题

项目摘要

Our concepts of platelet and megakaryocyte (Mk) origins and functions continue to expand. Mks are found in extramedullary tissues, including the lungs and spleen. We have shown that platelets initiate, accelerate, and regulate all phases of the immune responses and have now discovered that Mks have immune plasticity and functions that are dependent on their tissue environment. This includes our discovery that lung Mks take up, process, and present pathogen derived antigens to T cells. Our studies lead us to now hypothesize that: Mk differentiation is responsive to, and dictated by, environmental pathogens and/or stimuli. Our data also presents questions related to extramedullary Mk origins and differentiation. We will leverage the unique expertise of our collaborative team by using disease relevant in vitro and in vivo mouse model systems to explore this novel research inquiry. Proposed studies in this application will explore whether Mks differentiate from hematopoietic stem cells outside the bone marrow, determine the environmental regulators of Mk phenotype plasticity, and potential roles for extramedullary Mks in all phases of the immune responses. These studies will establish that tissue resident Mks have environmentally regulated roles in immune responses, changing how we view Mk and platelet functions, thereby impacting our understanding of major causes of morbidity and mortality. This includes infectious diseases such as bacterial pneumonias or viral infections (examples; influenza and coronavirus). To accomplish these paradigm shifting goals, we will pursue the following Aims: Aim #1. To demonstrate mechanisms of tissue dependent Mk differentiation. Aim #2. To demonstrate megakaryocyte immune regulatory roles.
我们对血小板和巨核细胞(Mk)的起源和功能的概念不断扩大。在

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CRAIG N MORRELL其他文献

CRAIG N MORRELL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CRAIG N MORRELL', 18)}}的其他基金

IMSD at the University of Rochester
罗彻斯特大学 IMSD
  • 批准号:
    10552964
  • 财政年份:
    2023
  • 资助金额:
    $ 50.91万
  • 项目类别:
Tissue Dependent Megakaryocyte Functions
组织依赖性巨核细胞功能
  • 批准号:
    10337469
  • 财政年份:
    2022
  • 资助金额:
    $ 50.91万
  • 项目类别:
Platelet-Regulated Immune Responses in Neonates Following Transfusion
新生儿输血后血小板调节的免疫反应
  • 批准号:
    10217253
  • 财政年份:
    2020
  • 资助金额:
    $ 50.91万
  • 项目类别:
Platelet-Regulated Immune Responses in Neonates Following Transfusion
新生儿输血后血小板调节的免疫反应
  • 批准号:
    10039184
  • 财政年份:
    2020
  • 资助金额:
    $ 50.91万
  • 项目类别:
ERK5 and CD36 link oxidative stress to platelet dysfunction and ischemic injury
ERK5 和 CD36 将氧化应激与血小板功能障碍和缺血性损伤联系起来
  • 批准号:
    10323025
  • 财政年份:
    2019
  • 资助金额:
    $ 50.91万
  • 项目类别:
Novel mechanisms of platelet modified monocyte phenotype
血小板修饰单核细胞表型的新机制
  • 批准号:
    10166903
  • 财政年份:
    2018
  • 资助金额:
    $ 50.91万
  • 项目类别:
Novel mechanisms of platelet modified monocyte phenotype
血小板修饰单核细胞表型的新机制
  • 批准号:
    10377113
  • 财政年份:
    2018
  • 资助金额:
    $ 50.91万
  • 项目类别:
Novel platelet functions for in T-cell helper cell responses
T 细胞辅助细胞反应中的血小板新功能
  • 批准号:
    9385749
  • 财政年份:
    2014
  • 资助金额:
    $ 50.91万
  • 项目类别:
Novel platelet functions for in T-cell helper cell responses
T 细胞辅助细胞反应中的血小板新功能
  • 批准号:
    8967578
  • 财政年份:
    2014
  • 资助金额:
    $ 50.91万
  • 项目类别:
Novel platelet functions for in T-cell helper cell responses
T 细胞辅助细胞反应中的血小板新功能
  • 批准号:
    8814885
  • 财政年份:
    2014
  • 资助金额:
    $ 50.91万
  • 项目类别:

相似海外基金

Modulation of hepatic acute phase reaction and antiviral response by pro-apaptotic substances (B13)
促凋亡物质调节肝脏急性期反应和抗病毒反应(B13)
  • 批准号:
    57771341
  • 财政年份:
    2008
  • 资助金额:
    $ 50.91万
  • 项目类别:
    Collaborative Research Centres
Effect of abnormal body temperature on ventilator induced lung injury and acute phase reaction
体温异常对呼吸机所致肺损伤及急性时相反应的影响
  • 批准号:
    18591710
  • 财政年份:
    2006
  • 资助金额:
    $ 50.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
gp130-dependent acute phase reaction: new therapeutical strategies to prevent vascular diseases (B 09)
gp130依赖性急性期反应:预防血管疾病的新治疗策略(B 09)
  • 批准号:
    5274832
  • 财政年份:
    2001
  • 资助金额:
    $ 50.91万
  • 项目类别:
    Collaborative Research Centres
NEUROPEPTIDERGIC MEDIATION OF THE ACUTE PHASE REACTION
急性期反应的神经肽能介导
  • 批准号:
    3477337
  • 财政年份:
    1988
  • 资助金额:
    $ 50.91万
  • 项目类别:
NEUROPEPTIDERGIC MEDIATION OF THE ACUTE PHASE REACTION
急性期反应的神经肽能介导
  • 批准号:
    3477338
  • 财政年份:
    1988
  • 资助金额:
    $ 50.91万
  • 项目类别:
NEUROPEPTIDERGIC MEDIATION OF THE ACUTE PHASE REACTION
急性期反应的神经肽能介导
  • 批准号:
    3477340
  • 财政年份:
    1988
  • 资助金额:
    $ 50.91万
  • 项目类别:
NEUROPEPTIDERGIC MEDIATION OF THE ACUTE PHASE REACTION
急性期反应的神经肽能介导
  • 批准号:
    3477339
  • 财政年份:
    1988
  • 资助金额:
    $ 50.91万
  • 项目类别:
NEUROPEPTIDERGIC MEDIATION OF THE ACUTE PHASE REACTION
急性期反应的神经肽能介导
  • 批准号:
    3477341
  • 财政年份:
    1988
  • 资助金额:
    $ 50.91万
  • 项目类别:
CENTRAL MONOAMINES IN ACUTE-PHASE REACTION
急性期反应中的中心单胺
  • 批准号:
    3405545
  • 财政年份:
    1986
  • 资助金额:
    $ 50.91万
  • 项目类别:
CENTRAL MONOAMINES AND OPIOIDS IN ACUTE-PHASE REACTION
急性期反应中的中心单胺和阿片类药物
  • 批准号:
    3405544
  • 财政年份:
    1986
  • 资助金额:
    $ 50.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了